NCT04603105Active, not recruiting
CCP Cancer UK Companion Study
Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK) - a Prospective Companion Study for Patients With Cancer and COVID-19
Source: ClinicalTrials.gov · Last updated 25 Feb 2025
Brief summary (registry, in English)
Currently, there is extremely limited information regarding the risks posed by SARS-CoV-2 to patients with cancer. This study aims to understand the presentation, management and outcomes of patients with cancer. The influence of cancer type and treatment will be explored as well as comparing cancer patients with non-cancer patients. This dataset, on robust analysis, will provide valuable information that would educate as well as help inform practice for future possible outbreaks. The information may also inform the development of guidelines with regard to the care and management of cancer patients with viruses such as COVID19 and similar infectious diseases. Cancer is immunosuppressive, the nature of the immunosuppression seems to be influenced by the microbiota, and in addition pulmonary infections
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 9000 (actual)
- First submitted
- 9 Oct 2020
- Start date
- 28 Feb 2021
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Diseases
- Childhood cancers
- NCT number
- NCT04603105
What you commit to
- Study type: Observational
- Participants enrolled: 9000
- From 28 Feb 2021 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- None in addition to those specified in the Principal CCP-UK protocol.
Who the study is looking for
- \- Patients with proven COVID-19 and a diagnosis of cancer who are enrolled into any Tier of the Principal CCP-UK protocol.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Clatterbridge Cancer Centre NHS Foundation Trust Coordinator of this site? Confirm its status | Liverpool | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.